{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T14:03:26Z","timestamp":1763129006909,"version":"3.45.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00415-025-13431-3","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:46:19Z","timestamp":1761061579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cervical cord atrophy correlates with intracranial lesion burden in tumefactive multiple sclerosis"],"prefix":"10.1007","volume":"272","author":[{"given":"Albert","family":"Aboseif","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin S.","family":"Jackson-Tarlton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher G.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Decker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew L.","family":"Kosel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiye","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. Mark","family":"Keegan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kejal","family":"Kantarci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanette E.","family":"Eckel-Passow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orhun H.","family":"Kantarci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burcu","family":"Zeydan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8141-2394","authenticated-orcid":false,"given":"W. Oliver","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"issue":"9","key":"13431_CR1","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1002\/acn3.51844","volume":"10","author":"M Fereidan-Esfahani","year":"2023","unstructured":"Fereidan-Esfahani M, Decker PA, Weigand SD et al (2023) Defining the natural history of tumefactive demyelination: a retrospective cohort of 257 patients. Ann Clin Transl Neurol 10(9):1544\u20131555. https:\/\/doi.org\/10.1002\/acn3.51844","journal-title":"Ann Clin Transl Neurol"},{"key":"13431_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.104614","volume":"73","author":"CS Jackson-Tarlton","year":"2023","unstructured":"Jackson-Tarlton CS, Keegan BM, Fereidan-Esfahani M et al (2023) Spinal cord and brain corticospinal tract lesions are associated with motor progression in tumefactive multiple sclerosis. Mult Scler Relat Disord 73:104614. https:\/\/doi.org\/10.1016\/j.msard.2023.104614","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"13431_CR3","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1136\/jnnp-2014-308021","volume":"86","author":"C Lukas","year":"2015","unstructured":"Lukas C, Knol DL, Sombekke MH et al (2015) Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis. J Neurol Neurosurg Psychiatry 86(4):410\u2013418. https:\/\/doi.org\/10.1136\/jnnp-2014-308021","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"13431_CR4","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000435","volume":"5","author":"B Zeydan","year":"2018","unstructured":"Zeydan B, Gu X, Atkinson EJ, Keegan BM, Weinshenker BG, Tillema JM, Pelletier D, Azevedo CJ, Lebrun-Frenay C, Siva A, Okuda DT, Kantarci K, Kantarci OH (2018) Cervical spinal cord atrophy: an early marker of progressive MS onset. Neurol Neuroimmunol Neuroinflamm 5(2):e435. https:\/\/doi.org\/10.1212\/NXI.0000000000000435","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"11","key":"13431_CR5","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1177\/1352458518781979","volume":"24","author":"BM Keegan","year":"2018","unstructured":"Keegan BM, Kaufmann TJ, Weinshenker BG, Kantarci OH, Schmalstieg WF, Paz Soldan MM, Flanagan EP (2018) Progressive motor impairment from a critically located lesion in highly restricted CNS-demyelinating disease. Mult Scler 24(11):1445\u20131452. https:\/\/doi.org\/10.1177\/1352458518781979","journal-title":"Mult Scler"},{"issue":"4","key":"13431_CR6","doi-asserted-by":"publisher","first-page":"e349","DOI":"10.1212\/WNL.0000000000005853","volume":"91","author":"C Tsagkas","year":"2018","unstructured":"Tsagkas C, Magon S, Gaetano L et al (2018) Spinal cord volume loss: a marker of disease progression in multiple sclerosis. Neurology 91(4):e349\u2013e358. https:\/\/doi.org\/10.1212\/WNL.0000000000005853","journal-title":"Neurology"},{"issue":"20","key":"13431_CR7","doi-asserted-by":"publisher","first-page":"e1852","DOI":"10.1212\/WNL.0000000000008466","volume":"93","author":"MA Rocca","year":"2019","unstructured":"Rocca MA, Valsasina P, Meani A, Gobbi C, Zecca C, Rovira \u00c0, Montalban X, Kearney H, Ciccarelli O, Matthews L, Palace J, Gallo A, Bisecco A, Gass A, Eisele P, Lukas C, Bellenberg B, Barkhof F, Vrenken H, Preziosa P, Comi G, Filippi M, MAGNIMS Study Group (2019) Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS. Neurology 93(20):e1852\u2013e1866. https:\/\/doi.org\/10.1212\/WNL.0000000000008466","journal-title":"Neurology"},{"issue":"2","key":"13431_CR8","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/ana.26281","volume":"91","author":"A Bischof","year":"2022","unstructured":"Bischof A, Papinutto N, Keshavan A, Rajesh A, Kirkish G, Zhang X, Mallott JM, Asteggiano C, Sacco S, Gundel TJ, Zhao C, Stern WA, Caverzasi E, Zhou Y, Gomez R, Ragan NR, Santaniello A, Zhu AH, Juwono J, Bevan CJ, Bove RM, Crabtree E, Gelfand JM, Goodin DS, Graves JS, Green AJ, Oksenberg JR, Waubant E, Wilson MR, Zamvil SS, University of California, San Francisco MS-EPIC Team, Cree BAC, Hauser SL, Henry RG (2022) Spinal cord atrophy predicts progressive disease in relapsing multiple sclerosis. Ann Neurol 91(2):268\u2013281. https:\/\/doi.org\/10.1002\/ana.26281","journal-title":"Ann Neurol"},{"issue":"5","key":"13431_CR9","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/ana.26341","volume":"91","author":"B Zeydan","year":"2022","unstructured":"Zeydan B, Rocca MA, Kantarci OH, Filippi M (2022) Spinal cord atrophy is a preclinical marker of progressive MS. Ann Neurol 91(5):734\u2013735. https:\/\/doi.org\/10.1002\/ana.26341","journal-title":"Ann Neurol"},{"issue":"4","key":"13431_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1212\/WNL.0000000000001186","volume":"84","author":"H Kearney","year":"2015","unstructured":"Kearney H, Altmann DR, Samson RS et al (2015) Cervical cord lesion load is associated with disability independently from atrophy in MS. Neurology 84(4):367\u2013373. https:\/\/doi.org\/10.1212\/WNL.0000000000001186","journal-title":"Neurology"},{"key":"13431_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.103713","volume":"60","author":"MM Weeda","year":"2022","unstructured":"Weeda MM, Zywicki S, Brouwer I, Moraal B, Killestein J, Gallo P, Barkhof F, Pouwels PJW, Vrenken H (2022) Upper cervical cord atrophy is independent of cervical cord lesion volume in early multiple sclerosis: a two-year longitudinal study. Mult Scler Relat Disord 60:103713. https:\/\/doi.org\/10.1016\/j.msard.2022.103713","journal-title":"Mult Scler Relat Disord"},{"key":"13431_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2022.103006","volume":"34","author":"M Bussas","year":"2022","unstructured":"Bussas M, El Husseini M, Harabacz L, Pineker V, Grahl S, Pongratz V, Berthele A, Riederer I, Zimmer C, Hemmer B, Kirschke JS, M\u00fchlau M (2022) Multiple sclerosis lesions and atrophy in the spinal cord: distribution across vertebral levels and correlation with disability. NeuroImage: Clinical 34:103006. https:\/\/doi.org\/10.1016\/j.nicl.2022.103006","journal-title":"NeuroImage: Clinical"},{"issue":"11","key":"13431_CR13","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/wnl.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444\u20131452. https:\/\/doi.org\/10.1212\/wnl.33.11.1444","journal-title":"Neurology"},{"issue":"3","key":"13431_CR14","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","volume":"83","author":"FD Lublin","year":"2014","unstructured":"Lublin FD, Reingold SC, Cohen JA et al (2014) Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83(3):278\u2013286. https:\/\/doi.org\/10.1212\/WNL.0000000000000560","journal-title":"Neurology"},{"issue":"Pt 11","key":"13431_CR15","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1093\/brain\/120.11.2059","volume":"120","author":"F Barkhof","year":"1997","unstructured":"Barkhof F, Filippi M, Miller DH, Scheltens P, Campi A, Polman CH, Comi G, Ad\u00e8r HJ, Losseff N, Valk J (1997) Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120(Pt 11):2059\u20132069. https:\/\/doi.org\/10.1093\/brain\/120.11.2059. (PMID: 9397021)","journal-title":"Brain"},{"issue":"9","key":"13431_CR16","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1212\/01.wnl.0000335764.14513.1a","volume":"72","author":"DT Okuda","year":"2009","unstructured":"Okuda DT, Mowry EM, Beheshtian A et al (2009) Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology 72(9):800\u2013805. https:\/\/doi.org\/10.1212\/01.wnl.0000335764.14513.1a","journal-title":"Neurology"},{"key":"13431_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102429","volume":"45","author":"TM Moog","year":"2020","unstructured":"Moog TM, McCreary M, Stanley T et al (2020) African Americans experience disproportionate neurodegenerative changes in the medulla and upper cervical spinal cord in early multiple sclerosis. Mult Scler Relat Disord 45:102429. https:\/\/doi.org\/10.1016\/j.msard.2020.102429","journal-title":"Mult Scler Relat Disord"},{"key":"13431_CR18","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.nicl.2016.05.017","volume":"11","author":"CG Schwarz","year":"2016","unstructured":"Schwarz CG, Gunter JL, Wiste HJ et al (2016) A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer\u2019s disease severity. NeuroImage: Clinical 11:802\u2013812. https:\/\/doi.org\/10.1016\/j.nicl.2016.05.017","journal-title":"NeuroImage: Clinical"},{"issue":"3 suppl","key":"13431_CR19","first-page":"563","volume":"28","author":"B Zeydan","year":"2022","unstructured":"Zeydan B, Neyal N, Schwarz CG et al (2022) Brain MRI versus spinal cord MRI in measuring cervical spinal cord atrophy. Mult Scler J 28(3 suppl):563","journal-title":"Mult Scler J"},{"key":"13431_CR20","doi-asserted-by":"publisher","DOI":"10.1177\/13524585241311441","author":"B Zeydan","year":"2025","unstructured":"Zeydan B, Son J, Neyal N et al (2025) Upper cervical spinal cord atrophy in MS: sex, menopause, and neurodegeneration. Mult Scler. https:\/\/doi.org\/10.1177\/13524585241311441","journal-title":"Mult Scler"},{"issue":"6","key":"13431_CR21","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/jon.12553","volume":"28","author":"C Casserly","year":"2018","unstructured":"Casserly C, Seyman EE, Alcaide-Leon P, Guenette M, Lyons C, Sankar S, Svendrovski A, Baral S, Oh J (2018) Spinal cord atrophy in multiple sclerosis: a systematic review and meta-analysis. J Neuroimaging 28(6):556\u2013586. https:\/\/doi.org\/10.1111\/jon.12553","journal-title":"J Neuroimaging"},{"issue":"7","key":"13431_CR22","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3174\/ajnr.A8304","volume":"45","author":"BM Keegan","year":"2024","unstructured":"Keegan BM, Messina SA, Hanson D, Holmes D, Camp J, Sechi E, Nayak S, Barakat B, Ahmad R, Mandrekar J, Harmsen WS, Kantarci O, Weinshenker BG, Flanagan EP (2024) MR imaging features of critical spinal demyelinating lesions associated with progressive motor impairment. AJNR Am J Neuroradiol 45(7):943\u2013950. https:\/\/doi.org\/10.3174\/ajnr.A8304","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"13431_CR23","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1177\/1352458512451510","volume":"19","author":"M Tutuncu","year":"2013","unstructured":"Tutuncu M, Tang J, Zeid NA et al (2013) Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis. Mult Scler 19(2):188\u2013198. https:\/\/doi.org\/10.1177\/1352458512451510","journal-title":"Mult Scler"},{"issue":"10","key":"13431_CR24","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1093\/brain\/awaa249","volume":"143","author":"R Ouellette","year":"2020","unstructured":"Ouellette R, Treaba CA, Granberg T et al (2020) 7 T imaging reveals a gradient in spinal cord lesion distribution in multiple sclerosis. Brain 143(10):2973\u20132987. https:\/\/doi.org\/10.1093\/brain\/awaa249","journal-title":"Brain"},{"issue":"7","key":"13431_CR25","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1093\/brain\/awaa162","volume":"143","author":"A Kerbrat","year":"2020","unstructured":"Kerbrat A, Gros C, Badji A et al (2020) Multiple sclerosis lesions in motor tracts from brain to cervical cord: spatial distribution and correlation with disability. Brain 143(7):2089\u20132105. https:\/\/doi.org\/10.1093\/brain\/awaa162","journal-title":"Brain"},{"issue":"1","key":"13431_CR26","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207768","volume":"102","author":"A Cagol","year":"2024","unstructured":"Cagol A, Benkert P, Melie-Garcia L, Schaedelin SA, Leber S, Tsagkas C, Barakovic M, Galbusera R, Lu PJ, Weigel M, Ruberte E, Radue EW, Yaldizli \u00d6, Oechtering J, Lorscheider J, D\u2019Souza M, Fischer-Barnicol B, M\u00fcller S, Achtnichts L, Vehoff J, Disanto G, Findling O, Chan A, Salmen A, Pot C, Bridel C, Zecca C, Derfuss T, Lieb JM, Remonda L, Wagner F, Vargas MI, Du Pasquier RA, Lalive PH, Pravat\u00e0 E, Weber J, Cattin PC, Absinta M, Gobbi C, Leppert D, Kappos L, Kuhle J, Granziera C (2024) Association of spinal cord atrophy and brain paramagnetic rim lesions with progression independent of relapse activity in people with MS. Neurology 102(1):e207768. https:\/\/doi.org\/10.1212\/WNL.0000000000207768","journal-title":"Neurology"},{"issue":"Pt 9","key":"13431_CR27","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1093\/brain\/123.9.1845","volume":"123","author":"N Evangelou","year":"2000","unstructured":"Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM (2000) Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain 123(Pt 9):1845\u20131849. https:\/\/doi.org\/10.1093\/brain\/123.9.1845","journal-title":"Brain"},{"issue":"5","key":"13431_CR28","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1111\/j.1750-3639.2010.00401.x","volume":"20","author":"T Dziedzic","year":"2010","unstructured":"Dziedzic T, Metz I, Dallenga T et al (2010) Wallerian degeneration: a major component of early axonal pathology in multiple sclerosis. Brain Pathol 20(5):976\u2013985. https:\/\/doi.org\/10.1111\/j.1750-3639.2010.00401.x","journal-title":"Brain Pathol"},{"issue":"1","key":"13431_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0831-8","volume":"14","author":"S Singh","year":"2017","unstructured":"Singh S, Dallenga T, Winkler A et al (2017) Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis. J Neuroinflammation 14(1):57. https:\/\/doi.org\/10.1186\/s12974-017-0831-8","journal-title":"J Neuroinflammation"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13431-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13431-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13431-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T14:01:01Z","timestamp":1763128861000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13431-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["13431"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13431-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"type":"print","value":"0340-5354"},{"type":"electronic","value":"1432-1459"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"11 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Albert Aboseif is sponsored by the Eugene and Marcia Applebaum Fellowship Award through the Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic. Caitlin S. Jackson-Tarlton reports consulting\/advisory for EMD Serono, Novartis, Roche, Biogen, Amgen Horizon, and clinical trial support from Roche. Christopher G. Schwarz receives research funding from NIH. Paul A. Decker reports no disclosures. Matthew L. Kosel reports no disclosures. B. Mark Keegan reports consulting for EMD Serono, Tr1X, Inc, Moderna, royalties from Oxford University Press Mayo Clinic Cases in Neuroimmunology. Kejal Kantarci serves on the Data Safety Monitoring Board for Takeda Pharmaceuticals. She is funded by the National Institutes of Health. Jeanette E. Eckel-Passow reports no disclosures Orhun H. Kantarci reports no disclosures. Burcu Zeydan receives funding from the National Institutes of Health [K12 AR084222]. W. Oliver Tobin has received research grant funding from the National Institutes of Health, the Mayo Clinic Center for MS and Autoimmune Neurology and book royalties from the publication of Mayo Clinic Cases in Neuroimmunology (Mayo Clinic Scientific Press) 2022.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"717"}}